Evidence map›Paper›PMID 37165114›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2023

Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas' cardiomyopathy.

Denise Mayumi Tanaka, Camila Godoy Fabricio, José A Marin-Neto, Antônio Carlos Leite de Barros Filho, Luciano Fonseca Lemos de Oliveira, Jorge Mejia, Rafael Ribeiro Almeida, Raquel de Souza Vieira, Carla Duque Lopes, Sabrina Setembre Batah and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Denise Mayumi TanakaMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Camila Godoy FabricioMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
José A Marin-NetoMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Antônio Carlos Leite de Barros FilhoMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Luciano Fonseca Lemos de OliveiraDepartment of Applied Physical Therapy, Institute of Health Sciences, Federal University of Triangulo Mineiro, Uberaba, Brazil.
Jorge MejiaHospital Israelita Albert Einstein, Sao Paulo, Brazil.
Rafael Ribeiro AlmeidaFaculty of Medicine, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil.
Raquel de Souza VieiraFaculty of Medicine, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil.
Carla Duque LopesMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Sabrina Setembre BatahMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Henrique Turin MoreiraMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Maria de Lourdes HiguchiFaculty of Medicine, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil.
Edecio Cunha NetoFaculty of Medicine, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil.
Alexandre Todorovic FabroMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Stephan G NekollaDepartment of Nuclear Medicine at Technische Universität, Munich, Germany.
Minna Moreira Dias RomanoMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil.
Marcus Vinícius SimõesMedical School of Ribeirao Preto, University of São Paulo, Sao Paulo, Brazil. msimoes@fmrp.usp.br.
Universidade de São Paulo · BRClinics Hospital of Ribeirão Preto · BRHospital Israelita Albert Einstein · BRTechnical University of Munich · DEUniversidade Federal do Triângulo Mineiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial perfusion defect (MPD) is common in chronic Chagas cardiomyopathy (CCC) and is associated with inflammation and development of left ventricular systolic dysfunction. We tested the hypothesis that pentoxifylline (PTX) could reduce inflammation and prevent the development of MPD in a model of CCC in hamsters. METHODS AND

resultsWe investigated with echocardiogram and rest myocardial perfusion scintigraphy at baseline (6-months after T. cruzi infection/saline) and post-treatment (after additional 2-months of PTX/saline administration), female Syrian hamsters assigned to 3 groups: T. cruzi-infected animals treated with PTX (CH + PTX) or saline (CH + SLN); and uninfected control animals (CO). At the baseline, all groups showed similar left ventricular ejection fraction (LVEF) and MPD areas. At post-treatment evaluation, there was a significant increase of MPD in CH + SLN group (0.8 ± 1.6 to 9.4 ± 9.7%), but not in CH + PTX (1.9 ± 3.0% to 2.7 ± 2.7%) that exhibited MPD area similar to CO (0.0 ± 0.0% to 0.0 ± 0.0%). The LVEF decreased in both infected groups. Histological analysis showed a reduced inflammatory infiltrate in CH + PTX group (395.7 ± 88.3 cell/mm

conclusionsThe prolonged use of PTX is associated with positive effects, including prevention of MPD development and reduction of inflammation in the chronic hamster model of CCC.

Indexed as

Chagas CardiomyopathyChagas DiseasePentoxifyllineAnimalsCricetinaeFemaleInflammationPerfusionStroke VolumeTomography, X-Ray ComputedVentricular Function, LeftPentoxifyllineChronic Chagas cardiomyopathycoronary microcirculationhamstersinflammationventricular dysfunction

Identifiers

PMID37165114
OpenAlexW4376133660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.